are all glp-1 the same Impact of Weight Loss Drugs on Food Choices GLP-1 vs Traditional Weight Loss

The market benefits from robust direct-to-consumer marketing efforts that drive patient demand and consultation rates

A comprehensive meta-analysis of eight GLP-1 RA CVOTs revealed several critical findings: 14% reduction in major adverse cardiovascular events (MACE: cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke) [3] 13% reduction in cardiovascular death [3] 10% reduction in all-cause mortality [3] 11% reduction in hospitalization for heart failure [3] Post-hoc analyzes from LEADER and SUSTAIN-6 revealed that cardiovascular benefits extended across the spectrum of body mass index categories, indicating efficacy regardless of baseline weight [2]

The Health and Healthcare Spending Effects of GLP-1s Glucagon-like peptide-1 receptor agonists (GLP-1s), better known by brand names such as Ozempic and Wegovy, have generated intense interest as potentially transformative treatments for type 2 diabetes and obesity

Most are once-weekly or daily GLP-1 injectable pens, while Rybelsus is a daily tablet